Clinical Trials on Extrapulmonary Small Cell Cancer

Total 10000 results

Boehringer Ingelheim
Zai Lab

Not yet recruiting

DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers

Small Cell Lung Cancer | Large Cell Neuroendocrine Lung Carcinoma | Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology | Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology

Belgium, Spain, United States, China, France, United Kingdom, Germany, Australia, Japan, Netherlands, Poland
National Cancer Institute (NCI)

Recruiting

Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors

Small Cell Lung Cancer | Non-Small Cell Lung Cancer | Extrapulmonary Small Cell Cancer | Pulmonary Neuroendocrine Tumors | Thymic Epithelial Tumors

United States
Case Comprehensive Cancer Center

Completed

Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC

Small-cell Lung Cancer | Large Cell Neuroendocrine Carcinoma of the Lung | Extrapulmonary Small Cell Carcinoma

United States
National Cancer Institute (NCI)

Withdrawn

Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer

Small Cell Carcinoma | Extensive-Stage Small Cell Lung Cancer | Extrapulmonary Neuroendocrine Carcinoma

United States
Boehringer Ingelheim

Recruiting

DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

Extrapulmonary Neuroendocrine Cancer (epNEC)

Belgium, Germany, Australia, United States, China, Spain, Japan, Canada, United Kingdom, France, Israel, Taiwan, Netherlands, Sweden, Finland, Denmark, Hong Kong, Brazil, Austria, Portugal, Italy, Czechia, Norway, New Zealand, South Korea, Chi... and more

Clinical Trials on Extrapulmonary Small Cell Cancer

This is a preview